Drugs / Mononuclear cells
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT07698080 | Jul 2026 → Jul 2028 expected | aplastic anemia, leukemia, lymphoma, myelodysplastic syndrome +1 | Hematology department of the 920th hospital | Not yet recruiting | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT05808010 | Jun 2023 → Apr 2025 | chronic atrophic gastritis | Shandong Provincial Hospital | Unknown | No outcome recorded |
| — | NCT06427642 | Apr 2022 → May 2024 | brain hypoxia - ischemia, bronchopulmonary dysplasia, short bowel syndrome | Shandong Qilu Stem Cells Engineering Co., Ltd. | Unknown | No outcome recorded |
| — | NCT04893629 | May 2021 → Nov 2024 | cardiomyopathy | Damascus University | Terminated | No outcome recorded |
| — | NCT02721940 | Feb 2012 → Jan 2015 | osteonecrosis | Chinese PLA General Hospital | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00908856 Comparator | Jan 2016 → Dec 2017 | stroke disorder | University of California, Irvine | Withdrawn | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT06629324 Comparator | Oct 2024 → Oct 2026 expected | autism spectrum disorder | Vinmec Research Institute of Stem Cell and Gene Technology | Recruiting | No outcome recorded |
| Phase 2 | NCT01456819 Comparator | Mar 2011 → Dec 2015 | limb ischemia | National University of Malaysia | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mono nuclear cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04893629 ↗ |
| Known as | Autologous Bone Marrow Mononuclear Cell Transfusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06629324 ↗ |
| Modality | Cell therapy | “Cell therapy with mononuclear cells and mesenchymal stem cells from bone marrow is promising” NCT01456819 ↗ |
| Route | Intravenous | “a single intravenous transfusion approximately 2 days after bone marrow aspiration, and 4 days after stroke onset” NCT00908856 ↗ |